Wattanosoth Taps Mayo Clinic to Lead Asia Cancer Care
Wattanosoth Cancer Hospital engages Mayo Clinic Global Consulting to elevate clinical standards and become the top cancer hub in the Asia-Pacific region.
As Thailand aggressively solidifies its position as the "Medical Hub of Asia," private hospitals are increasingly seeking global alliances to elevate clinical standards. In a major strategic move, Wattanosoth Cancer Hospital, the country's first private cancer institution, has announced an engagement with Mayo Clinic Global Consulting.
This collaboration comes as the healthcare sector shifts toward Precision Medicine—a trend focused on tailoring treatment to individual genetic profiles. Under an 8-month consulting contract, Wattanosoth will leverage Mayo Clinic’s world-renowned expertise to refine its organizational objectives and clinical practices.
The immediate focus will be on advancing early detection, staging, and novel treatments for breast cancer, a high-priority segment in oncology.
Elevating Standards in the APAC Region The partnership aims to accelerate Wattanosoth's goal of becoming the premier advanced cancer hub in the Asia-Pacific region.
By adopting Mayo Clinic’s integrated clinical care and practice models, the hospital intends to unlock new levels of operational effectiveness and service line growth.
"With nearly 20 years of expertise, we are striving for healthcare excellence that emphasizes treatment outcomes," the hospital stated. This move reinforces their "360° Total Cancer Care Solution," positioning the hospital not just as a treatment facility, but as a center for holistic recovery.
Proven Excellence and Technology Wattanosoth already boasts competitive clinical outcomes, reporting a 5-year survival rate of over 95% for early-stage breast and lung cancers. The hospital utilizes cutting-edge technology, including EDGE Radiosurgery and an in-house genomic laboratory capable of Next-Generation Sequencing (NGS).
Beyond the Cure: Patient-Centric Focus Aligning with global healthcare trends, the hospital is also adopting standards from the International Consortium for Health Outcomes Measurement (ICHOM). Through its "Care Beyond Cure Program," Wattanosoth is shifting focus to the entire patient journey—supporting body, mind, and society—ensuring that Thailand’s medical offerings compete on quality of life, not just medical procedure success.
